---
title: "Roche Holding AG (RHHVF.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/RHHVF.US.md"
symbol: "RHHVF.US"
name: "Roche Holding AG"
industry: "Pharmaceuticals"
---

# Roche Holding AG (RHHVF.US)

| Item | Detail |
|------|--------|
| Industry | Pharmaceuticals |
| Location | US Market |
| Website | [www.roche.com](https://www.roche.com) |

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-03-01T04:30:12.000Z

**Overall: B (0.36)**

**Industry**: Pharmaceuticals

| Metric | Value |
|--------|-------|
| Industry Ranking | 2 / 188 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Large - The company has stable operations, allowing for dependable long-term returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 10.62% |  |
| Net Profit YoY | 69.52% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 9.57 |  |
| Dividend Ratio | 2.58% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 408.15B |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 77.82B |  |


**Multi Score**: B

#### Profit Score: A

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 39.29% | A |
| Profit Margin | 20.33% | A |
| Gross Margin | 74.49% | A |

#### Growth Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 10.62% | B |
| Net Profit YoY | 69.52% | A |
| Total Assets YoY | 12.85% | B |
| Net Assets YoY | 19.50% | A |

#### Cash Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | 491.89% | C |
| OCF YoY | 10.62% | B |

#### Operating Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 0.63 | B |

#### Debt Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 62.38% | D |


```chart-data:radar
{
  "title": "Longbridge Financial Score - Roche Holding AG",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "A",
      "indicators": [
        {
          "name": "ROE",
          "value": "39.29%",
          "rating": "A"
        },
        {
          "name": "Profit Margin",
          "value": "20.33%",
          "rating": "A"
        },
        {
          "name": "Gross Margin",
          "value": "74.49%",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "B",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "10.62%",
          "rating": "B"
        },
        {
          "name": "Net Profit YoY",
          "value": "69.52%",
          "rating": "A"
        },
        {
          "name": "Total Assets YoY",
          "value": "12.85%",
          "rating": "B"
        },
        {
          "name": "Net Assets YoY",
          "value": "19.50%",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "C",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "491.89%",
          "rating": "C"
        },
        {
          "name": "OCF YoY",
          "value": "10.62%",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "B",
      "indicators": [
        {
          "name": "Turnover",
          "value": "0.63",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "D",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "62.38%",
          "rating": "D"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | Eli Lilly (US.LLY) | A | A | B | E | B | B |
| 02 | ROCHE HOLDINGS AG (US.RHHVF) | A | B | B | D | C | B |
| 03 | Roche (US.RHHBY) | A | B | B | D | C | B |
| 04 | AstraZeneca (US.AZN) | A | B | C | D | C | B |
| 05 | NOVARTIS AG (US.NVS) | A | B | C | D | C | B |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 25.80 | 42/257 | 29.72 | 27.36 | 25.30 |
| PB | 9.57 | 171/257 | 9.31 | 7.78 | 7.27 |
| PS (TTM) | 5.24 | 98/257 | 4.60 | 3.80 | 3.62 |
| Dividend Yield | 2.58% | 16/257 | 3.61% | 3.34% | 3.02% |

## References

- [Company Overview](https://longbridge.com/en/quote/RHHVF.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/RHHVF.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/RHHVF.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.